Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
Manufacturing
Return to: PBR Home | Production & Manufacturing | Manufacturing

Manufacturing

Kitov announces completion of manufacturing pivotal batches of KIT-302 for registration in US Kitov Pharmaceuticals announced the completion of manufacturing by Dexcel Pharma of pivotal batches required for registration of KIT-302 with the US Food and Drug Administration (FDA).
Production & Manufacturing > Manufacturing > News
Bristol-Myers Squibb expands Devens biologics facility in Massachusetts Bristol-Myers Squibb has completed a major expansion at its Devens, Massachusetts biologics facility designed to accelerate development of the company’s growing portfolio of biologics medicines.
Production & Manufacturing > Manufacturing > News Pfizer blocks drugs from use in lethal injections By PBR Staff Writer
Pharmaceutical giant Pfizer has blocked the use of its products in some of the US states that permit lethal injections.
Production & Manufacturing > Manufacturing > News
See more Manufacturing news

Latest Manufacturing News and Insight

View all Manufacturing news or find news targeted to your interests
Neovacs, Stellar Biotechnologies sign JV deal to make conjugated therapeutic vaccines
By PBR Staff Writer
Neovacs and Stellar Biotechnologies have signed a joint venture (JV) agreement to manufacture and sell conjugated therapeutic vaccines using Stellar’s Keyhole Limpet Hemocyanin.
Production & Manufacturing > Manufacturing > News
HIgh Shear Bin Blender
IBC blenders have been for decades the best dry material blending technology available for 3,000 liter or smaller batch blending. This is due to the unparalleled blend uniformity capability, speed of blend and the fact that the blender itself has no product contact components that allows immediate product changeover. The only limitation with this technology has been that it is a low shear blending principle as it relies on the simple yet highly effective tumble action to produce homogeneous blends. On occasion high shear is required for batches with ingredients that tend to agglomerate during blending and that required a change to a blender with high shear blending principle; this is no longer necessary.
Production & Manufacturing > Manufacturing > Products
Restricted Access Barrier System
Restricted Access Barrier Systems are rigid walls that provide a physical barrier between operators and the manufacturing process to prevent migration or segregation of product or to reduce operator exposure. Introduction or removal of materials can be done through glove ports or doors depending on the level of containment required. Come to Booth 1053 to see a barrier and discuss your containment or powder processing needs with our experts.
Production & Manufacturing > Manufacturing > Products
JHL Biotech opens biosimilars manufacturing plant in China
Biopharmaceutical firm JHL Biotech (JHL) has opened the world’s first KUBio biopharmaceutical manufacturing facility with single-use bioprocessing technology in Wuhan, China.
Production & Manufacturing > Manufacturing > News
Analytica 2016 at Messe München
Molnár-Institute opened the first day at analytica 2016 at Messe München in Munich, Germany. This year marks the 25th anniversary of Europe’s premier trade fair for laboratory technology, analysis and biotechnology.
Production & Manufacturing > Manufacturing > Press Releases
AMRI to buy Italian API maker Euticals for $358m
By PBR Staff Writer
Albany Molecular Research (AMRI) has agreed to acquire Italy-based active pharmaceuticals ingredients (API) manufacturer Prime European Therapeuticals, also known as Euticals, for about $358.
Production & Manufacturing > Manufacturing > News
Merck to expand Carlsbad viral and gene therapy plant in California
Merck has announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products.
Production & Manufacturing > Manufacturing > News
EMD Serono expands biopharmaceutical R&D facility in Billerica, Massachusetts
EMD Serono, the biopharmaceutical business of Merck KGaA, in North America, announced a $12m investment for the expansion of its R&D facility in Billerica, Massachusetts.
Production & Manufacturing > Manufacturing > News
Alnylam breaks ground on new manufacturing Facility in Norton, Massachusetts
Alnylam Pharmaceuticals has break ground on a biopharmaceutical manufacturing facility in Norton, Massachusetts.
Production & Manufacturing > Manufacturing > News
AbbVie agrees to buy Stemcentrx for $5.8bn
By PBR Staff Writer
AbbVie has agreed to acquire cancer drug startup Stemcentrx in a transaction valued at about $5.8bn.
Production & Manufacturing > Manufacturing > News
View all Manufacturing news or find news targeted to your interests